Imagine having a really bad cold that never goes away—congestion, runny nose, facial pressure, headache and loss of smell for more than three months. That’s what it feels like to the more than 36 million people in the U.S. who suffer from chronic rhinosinusitis (CRS), a persistent inflammatory condition of the nasal and sinus cavity lining.
It has been an action-packed 12 months for EnSpectra Health, a Fogarty Institute company that is leading a digital transformation in skin cancer pathology. While 2019 brought a number of notable developments, most recently EnSpectra received a $2 million grant that will expedite the introduction of its groundbreaking skin cancer identification technology.
The growing size and influence of the much-anticipated 38th Annual J.P. Morgan Healthcare Conference continues to drive high attendance and concurrent events. This year, the Fogarty Institute played a larger role by hosting its first Innovator’s reception in partnership with Stanford Biodesign, The MedTech Strategist, RCT and the MedTech Innovator.
The reception was a success,
Going to the doctor is not always a preferred activity, and part of that is the testing involved, including, of course, the ubiquitous urine test. This remains a standard method used to determine the proper course of treatment for patients and to prevent exposure to potentially harmful medications and procedures. Point-of-care urine tests are used to diagnose a range of conditions,
Thanks to improved tooth-brushing habits, regular dental care and ubiquitous fluoridation, most Americans have benefited from better tooth health. And yet, many still lose their teeth, whether due to injury, decay or periodontal disease. In fact, studies find that approximately 178 million people in the United States are missing at least one tooth, and a surprising 40 million are missing all their teeth.
A seasoned medtech entrepreneur and executive, Rod Young has seen the industry from a variety of perspectives – as a division leader and eventually president of sizable companies; as an advisor and board member; and as an entrepreneur who founded, launched, took public and then sold medtech startups.
And as in the case with most luminaries in the industry,
Imagine going to the doctor’s office for your annual check-up. The nurse starts going through the usual tests, such as measuring your blood pressure, heart rate and temperature and completing the blood draw from your arm.
Then the nurse immediately starts testing your blood with a hand-held device, explaining that instead of waiting for the sample to return from the lab,
A surgeon, an educator and a physician entrepreneur, James Wall, MD, has already accomplished more than most in his budding career. Recently named co-director of Stanford Biodesign’s Innovation Fellowship, he is an assistant professor of surgery at Stanford University where he focuses on minimally invasive approaches to children’s surgery. He has developed multiple medical devices,
From damp armpits to clammy palms, nearly one in 20 people in the U.S. suffers from hyperhidrosis. Also known as excessive sweating, this condition can significantly impair quality of life, confidence and emotional well-being as it limits activities, work and social relationships.
Enspectra Health, a Fogarty Institute company that is leading a digital transformation in skin cancer pathology, recently closed a $7.5 million Series A round led by Tsingyuan Ventures, a technology-focused venture fund based in Los Altos, Calif.
Funding success will serve several needs
“Fundraising has been one of our major focuses as we seek to take the startup to the next level,” said Gabriel Sanchez,